Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Precision Medicine in Non Communicable Diseases Publisher



Hasanzad M1, 2 ; Sarhangi N2 ; Meybodi HRA2 ; Nikfar S2, 3 ; Khatami F4 ; Larijani B2, 5
Authors

Source: International Journal of Molecular and Cellular Medicine Published:2019


Abstract

Non-communicable diseases (NCDs) are the leading cause of death and disease burden globally, cardiovascular diseases (CVDs) account for the major part of death related to NCDs followed by different types of cancer,chronic obstructive pulmonary disease (COPD), and diabetes. As the World Health Organization (WHO) andthe United Nations have announced a 25% reduction in mortality of NCDs by 2025, different communities needto adopt preventive strategies for achieving this goal. Personalized medicine approach as a predictive andpreventive strategy aims for a better therapeutic goal to the patients to maximize benefits and reduce harms. Theclinical benefits of this approach are already realized in cancer targeted therapy, and its impact on otherconditions needs more studies in different societies. In this review, we essentially describe the concept ofpersonalized (or precision) medicine in association with NCDs and the future of precision medicine inprediction, prevention, and personalized treatment © 2019, International Journal of Molecular and Cellular Medicine. All Rights Reserved.
Related Docs
View other Related Docs
1. Precision Medicine in Endocrinology Practice, Precision Medicine in Clinical Practice (2022)
2. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope, Acta Medica Iranica (2017)
3. Personalized Cancer Therapies, (2024)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (8)
Shekoufeh Nikfar (4)
Other Related Docs
4. Personalized Medicine and Therapeutics, (2024)
5. Diabetes Mellitus, Obesity, and Risk of Pancreatic Ductal Adenocarcinoma: A Large Case-Control Study From Iran, Middle East Journal of Digestive Diseases (2021)
6. Crossing the Way of Precision Medicine Approach in Personalized Medicine Research Center: A Systematic Review, Iranian Journal of Diabetes and Metabolism (2021)
7. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
8. Tumor Immunology, Clinical Immunology (2022)
9. Investigating the Role of Circulating Tumor Cells in Gastric Cancer: A Comprehensive Systematic Review and Meta-Analysis, Clinical and Experimental Medicine (2024)
10. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
11. A Narrative Review of Current Trends in Liraglutide: Insights Into the Unmet Needs in Management of Type 2 Diabetes and Obesity, Journal of Diabetes and Metabolic Disorders (2020)
12. Role of Btla/Hvem Network in Development of Gastric Cancer, Human Immunology (2022)
13. Analysis of the Results of Cardiovascular Disease Risk Assessment Program, Journal of Babol University of Medical Sciences (2021)
14. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
15. Nanoparticles for Biosensing, Advanced Structured Materials (2019)
16. The Lost Productivity Cost of Premature Mortality Owing to Cancers in Iran: Evidence From the Globocan 2012 to 2018 Estimates, Value in Health Regional Issues (2022)
17. Principles of Precision Medicine, Precision Medicine in Clinical Practice (2022)
18. Iran in Transition, The Lancet (2019)
19. A 10-Year Isfahan Cohort on Cardiovascular Disease As a Master Plan for a Multi-Generation Non-Communicable Disease Longitudinal Study: Methodology and Challenges, Journal of Human Hypertension (2019)
20. Importance of Population-Wide Studies in Controlling Noncommunicable Diseases: Achievements of Non-Communicable Diseases Research Center, Endocrinology and Metabolism Research Institute, Iranian Journal of Diabetes and Metabolism (2021)